Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management

Scaroni, Carla, Zilio, Marialuisa, Foti, Michelangelo, Boscaro, Marco·2017·Endocrine Reviews
DOI 10.1210/er.2016-1105

Cites (383)

Items 201–363 of 363

  1. Thioredoxin-Interacting Protein: Pathophysiology and Emerging Pharmacotherapeutics in Cardiovascular Disease and Diabetes
    Cher‐Rin Chong, Wai Ping Alicia Chan, Thanh Ha Tuan Nguyen, Saifei Liu, Nathan E. K. Procter, Doan T M Ngo, Aaron Leonid Sverdlov, Yuliy Y. Chirkov, John David Horowitz · 2014 · Cardiovascular Drugs and Therapy
  2. A reappraisal of the medical therapy with steroidogenesis inhibitors in <scp>C</scp>ushing's syndrome
    Valassi, Elena, Crespo, Iris, Gich, Ignasi, Rodríguez, José, Webb, Susan M. · 2012 · Clinical Endocrinology
  3. Screening of Cushing’s syndrome in adult patients with newly diagnosed diabetes mellitus
    Reimondo, Giuseppe, Pia, Anna, Allasino, Barbara, Tassone, Francesco, Bovio, Silvia, Borretta, Giorgio, Angeli, Alberto, Terzolo, Massimo · 2007 · Clinical Endocrinology
  4. Screening of Cushing’s syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy
    Terzolo, Massimo, Reimondo, Giuseppe, Chiodini, Iacopo, Castello, Roberto, Giordano, Roberta, Ciccarelli, Enrica, Limone, Paolo, Crivellaro, Claudio, Martinelli, Irma, Montini, Marcella et al. · 2012 · The Journal of Clinical Endocrinology &amp; Metabolism
  5. Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma
    Terzolo, Massimo, Bovio, Silvia, Pia, Anna, Conton, Pier Antonio, Reimondo, Giuseppe, Dall’Asta, Chiara, Bemporad, Donatella, Angeli, Alberto, Opocher, Giuseppe, Mannelli, Massimo et al. · 2005 · European Journal of Endocrinology
  6. Colocalization of Somatostatin Receptor sst5 and Insulin in Rat Pancreatic β-Cells*
    Sudha R. Warrier, Éva Mezey, Béla Hunyady, LaShawn Chamberlain, Edward C. Hayes, Forrest Foor, Yining Wang, Agnes Schönbrunn, James M. Schaeffer · 1999 · Endocrinology
  7. Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas
    Bernini, G P, Moretti, A, Oriandini, C, Bardini, M, Taurino, C, Salvetti, A · 2005 · British Journal of Cancer
  8. Glucocorticoid hormones and energy homeostasis
    Roldan M. de Guia, Adam J. Rose, Stephan Herzig · 2014 · Hormone Molecular Biology and Clinical Investigation
  9. Effect of Pioglitazone on Adrenocorticotropic Hormone and Cortisol Secretion in Cushing’s Disease
    D. Suri, Roy E. Weiss · 2005 · The Journal of Clinical Endocrinology & Metabolism
  10. Vertebral fractures in males with type 2 diabetes treated with rosiglitazone
    Tatiana Mancini, Gherardo Mazziotti, Mauro Doga, Rita Carpinteri, Niksa Simetovic, Pier Paolo Vescovi, Andrea Giustina · 2009 · Bone
  11. Changes in Adenosine 5′-Monophosphate-Activated Protein Kinase as a Mechanism of Visceral Obesity in Cushing’s Syndrome
    Blerina Kola, Mirjam Christ‐Crain, Francesca Lolli, Giorgio Arnaldi, Gilberta Giacchetti, Marco Boscaro, Ashley Barry Grossman, Márta Korbonits · 2008 · The Journal of Clinical Endocrinology & Metabolism
  12. Glucocorticoids and Thiazolidinediones Interfere with Adipocyte-mediated Macrophage Chemotaxis and Recruitment
    David Patsouris, Jaap G. Neels, WuQiang Fan, Pingping Li, Matthew T. Nguyen, Jerrold M. Olefsky · 2009 · Journal of Biological Chemistry
  13. Effect of protracted treatment with rosiglitazone, a PPARγ agonist, in patients with Cushing's disease
    Francesca Pecori Giraldi, Carla Maria Scaroni, Emanuela Arvat, Martina De Martin, Roberta Giordano, Nora Maria Elvira Albiger, Adriana Antonio Silva Leão, Andreea Picu, Franco Mantero, Francesco Cavagnini · 2006 · Clinical Endocrinology
  14. Aged Transgenic Mice With Increased Glucocorticoid Sensitivity in Pancreatic β-Cells Develop Diabetes
    Behrous Davani, Neil Portwood, Galina Bryzgalova, Martina Kvist Reimer, Thomas Heiden, Claes‐Göran Östenson, Sam Okret, Bo Åhrén, Suad Efendić, Akhtar Khan · 2004 · Diabetes
  15. Pathogenesis of hepatic steatosis: The link between hypercortisolism and non-alcoholic fatty liver disease
    Giovanni Tarantino · 2013 · World Journal of Gastroenterology
  16. Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study
    Sereg, Márta, Szappanos, Ágnes, Tőke, Judit, Karlinger, Kinga, Feldman, Karolina, Kaszper, Éva, Varga, Ibolya, Gláz, Edit, Rácz, Károly, Tóth, Miklós · 2009 · European Journal of Endocrinology
  17. Fat cells may be the obesity-hypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells
    Ehrhart‐Bornstein, Monika, Arakelyan, Karen, Krug, Alexander W., Scherbaum, Werner A., Bornstein, Stefan R. · 2004 · Endocrine Research
  18. Is diabetes in Cushing’s syndrome only a consequence of hypercortisolism?
    Giordano, Carla, Guarnotta, Valentina, Pivonello, Rosario, Amato, Marco Calogero, Simeoli, Chiara, Ciresi, Alessandro, Cozzolino, Alessia, Colao, Annamaria · 2014 · European Journal of Endocrinology
  19. 11β-HSD1 Inhibitors for the Treatment of Type 2 Diabetes and Cardiovascular Disease
    Anna Anderson, Brian Robert Walker · 2013 · Drugs
  20. Hypercortisolemia and Infection
    Gilbert G. Fareau, Rena Vassilopoulou‐Sellin · 2007 · Infectious Disease Clinics of North America
  21. Glucocorticoid Modulation of Insulin Signaling in Human Subcutaneous Adipose Tissue
    Gathercole, Laura L., Bujalska, Iwona J., Stewart, Paul M., Tomlinson, Jeremy W. · 2007 · The Journal of Clinical Endocrinology &amp; Metabolism
  22. Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy
    Anat Ben-Shlomo, HERBERT A. SCHMID, Kolja Wawrowsky, Oksana Pichurin, Erika Hubina, Vera Chesnokova, Ning‐Ai Liu, Michael D. Culler, Shlomo K. Melmed · 2009 · The Journal of Clinical Endocrinology & Metabolism
  23. Glucocorticoid increases glucose cycling and inhibits insulin release in pancreatic islets of ob/ob mice.
    Akhtar Khan, C. Östenson, P. Berggren, S. Eféndic · 1992 · American Journal of Physiology
  24. Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes
    David Hebbelstrup Jensen, Kasper Aaboe, Jan Erik Henriksen, A. Vølund, Jens Juul Holst, Sten Madsbad, Thure Krarup · 2012 · Diabetologia
  25. Role of Plasminogen Activator Inhibitor-1 in Glucocorticoid-Induced Diabetes and Osteopenia in Mice
    Yukinori Tamura, Naoyuki Kawao, Masato Yano, Kiyotaka Okada, Katsumi Okumoto, Yasutaka Chiba, Osamu Matsuo, Hiroshi Kaji · 2014 · Diabetes
  26. Influence of glucocorticoids and growth hormone on insulin sensitivity in humans
    Kevin C.J. Yuen, L. E. Chong, M. Riddle · 2013 · Diabetic Medicine
  27. The prevalence and management of hyperglycaemia in patients with rheumatoid arthritis on corticosteroid therapy
    Panthakalam, S, Bhatnagar, D, Klimiuk, P · 2004 · Scottish Medical Journal
  28. Glucocorticoid Signaling in the Arcuate Nucleus Modulates Hepatic Insulin Sensitivity
    Chun‐Xia Yi, Ewout Foppen, William A. Abplanalp, Yuanqing Gao, Anneke Alkemade, Susanne Eva la Fleur, Mireille J. M. Serlie, Eric Fliers, Ruud M. Buijs, Matthias H. Tschöp et al. · 2011 · Diabetes
  29. Posterior Retroperitoneoscopic Adrenalectomy for Clinical and Subclinical Cushing’s Syndrome
    Pier Francesco Alesina, Silvia Hommeltenberg, Beate Meier, Stephan Petersenn, Harald Lahner, Kurt Werner Schmid, Klaus Mann, Martin Karl Walz · 2010 · World Journal of Surgery
  30. Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency
    Mazziotti, G, Porcelli, T, Bianchi, A, Cimino, V, Patelli, I, Mejia, C, Fusco, A, Giampietro, A, De Marinis, L, Giustina, A · 2010 · European Journal of Endocrinology
  31. Glucocorticoid induced insulin resistance impairs basal but not glucose entrained high-frequency insulin pulsatility in humans
    Hollingdal, M., Juhl, C. B., Dall, R., Sturis, J., Veldhuis, J. D., Schmitz, O., Pørksen, N. · 2002 · Diabetologia
  32. Subclinical Cushing's syndrome
    Massimo Terzolo, Silvia Bovio, Anna Rosa Pia, Giangiacomo Osella, Giorgio Borretta, Alberto Angeli, Giuseppe Reimondo · 2007 · Arquivos Brasileiros de Endocrinologia & Metabologia
  33. Treatment of Cushing disease: overview and recent findings
    Giustina, Andrea · 2010 · Therapeutics and Clinical Risk Management
  34. Managing Cushing’s disease: the state of the art
    Annamaria Colao, Marco Boscaro, Diego Ferone, Felipe F. Casanueva · 2014 · Endocrine
  35. Glucocorticoids Fail to Cause Insulin Resistance in Human Subcutaneous Adipose Tissue In Vivo
    Hazlehurst, Jonathan M., Gathercole, Laura L., Nasiri, Maryam, Armstrong, Matthew J., Borrows, Sarah, Yu, Jinglei, Wagenmakers, Anton J. M., Stewart, Paul M., Tomlinson, Jeremy W. · 2013 · The Journal of Clinical Endocrinology &amp; Metabolism
  36. Pancreatic Alpha-Cell Dysfunction Contributes to the Disruption of Glucose Homeostasis and Compensatory Insulin Hypersecretion in Glucocorticoid-Treated Rats
    Alex Rafacho, Luiz M. Gonçalves-Neto, Junia Carolina Santos-Silva, Paloma Alonso‐Magdalena, Beatriz Merino, Sebastião Roberto Taboga, Everardo M. Carneiro, Antonio Carlos Boschero, Ángel Nadal, Iván Quesada · 2014 · PLoS ONE
  37. Growth hormone deficiency in the adult
    Mauro Doga, Stefania Bonadonna, Monica Gola, Gherardo Mazziotti, A. Giustina · 2006 · Pituitary
  38. Prednisolone-induced beta cell dysfunction is associated with impaired endoplasmic reticulum homeostasis in INS-1E cells
    Margot M. L. Linssen, Daniël H. van Raalte, Erik J. M. Toonen, Wynand B. L. Alkema, Gerard C. van der Zon, Wim H.A. Dokter, Michaëla Diamant, Bruno Guigas, D. Margriet Ouwens · 2011 · Cellular Signalling
  39. Is there value in routine screening for Cushing’s syndrome in patients with diabetes?
    Mullan, K., Black, N., Thiraviaraj, A., Bell, P. M., Burgess, C., Hunter, S. J., McCance, D. R., Leslie, H., Sheridan, B., Atkinson, A. B. · 2010 · The Journal of Clinical Endocrinology &amp; Metabolism
  40. Efficacy of medical treatment in C ushing's disease: a systematic review
    Mônica R. Gadelha, Leonardo Vieira Neto · 2013 · Clinical Endocrinology
  41. Metabolic, Cardiovascular, and Cerebrovascular Outcomes in Growth Hormone-Deficient Subjects with Previous Cushing’s Disease or Non-Functioning Pituitary Adenoma
    Susan M. Webb, Daojun Mo, Steven W. J. Lamberts, Shlomo K. Melmed, Francesco Cavagnini, Francesca Pecori Giraldi, Christian Joseph Strasburger, Alan G. Zimmermann, Whitney W. Woodmansee, on behalf of the International HypoCCS Advisory Board · 2009 · The Journal of Clinical Endocrinology & Metabolism
  42. Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing’s disease: results from an open-ended, open-label extension trial
    Jochen Schopohl, Feng Gu, Robert Rubens, Luc Van Gaal, Jerome Yves Bertherat, Monica Ligueros‐Saylan, Andrew Trovato, Gareth Hughes, Luiz Roberto Salgado, Marco Boscaro et al. · 2014 · Pituitary
  43. Bilateral and unilateral adrenal incidentalomas: biochemical and clinical characteristics
    Morelli, V, Palmieri, S, Salcuni, A S, Eller-Vainicher, C, Cairoli, E, Zhukouskaya, V, Scillitani, A, Beck-Peccoz, P, Chiodini, I · 2013 · European Journal of Endocrinology
  44. Untitled work
    Vassilatou · 2014 · 10.1530/eje-13-0848
  45. Diabetes, Hyperglycemia, and Infections
    Ashley Shilling, Jacob Raphael · 2008 · Best practice & research. Clinical anaesthesiology
  46. Mifepristone Reduces Insulin Resistance in Patient Volunteers with Adrenal Incidentalomas That Secrete Low Levels of Cortisol: A Pilot Study
    Miguel Debono, Rita Chadarévian, Richard Eastell, Richard John M Ross, John D C Newell-Price · 2013 · PLoS ONE
  47. Lack of evidence for a role of TRB3/NIPK as an inhibitor of PKB-mediated insulin signalling in primary hepatocytes
    Patrick B. Iynedjian · 2005 · Biochemical Journal
  48. Non-parallelism of islet amyloid polypeptide (amylin) and insulin gene expression in rat islets following dexamethasone treatment
    Hindrik Mulder, Bo Ahr�n, Mats Stridsberg, F. Sundler · 1995 · Diabetologia
  49. Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden
    Olsen, Henrik, Nordenström, Erik, Bergenfelz, Anders, Nyman, Ulf, Valdemarsson, Stig, Palmqvist, Erik · 2012 · Endocrine
  50. Insulin resistance induced by hydrocortisone is increased in patients with abdominal obesity
    Darmon, Patrice, Dadoun, Frédéric, Boullu-Ciocca, Sandrine, Grino, Michel, Alessi, Marie-Christine, Dutour, Anne · 2006 · American Journal of Physiology-Endocrinology and Metabolism
  51. Pros and cons of screening for occult Cushing syndrome
    Tabarin, Antoine, Perez, Paul · 2011 · Nature Reviews Endocrinology
  52. Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adults
    Charlisa D. Gibson, Wahida Karmally, Donald J. McMahon, Sharon L. Wardlaw, Judith Körner · 2011 · Diabetes Obesity and Metabolism
  53. Management of hyperglycaemia in Cushing's disease: Experts’ proposals on the use of pasireotide
    Yves Reznik, Jerome Yves Bertherat, Françoise Borson‐Chazot, Thierry Christian Brue, Philippe Chanson, Christine Cortet‐Rudelli, Brigitte Delemer, Antoine Tabarin, Ségolène Bisot-Locard, Bruno L Vergès · 2012 · Diabetes & Metabolism
  54. The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism
    Palmieri, S, Morelli, V, Polledri, E, Fustinoni, S, Mercadante, R, Olgiati, L, Eller Vainicher, C, Cairoli, E, Zhukouskaya, V V, Beck-Peccoz, P et al. · 2013 · European Journal of Endocrinology
  55. Involvement of thioredoxin-interacting protein (TXNIP) in glucocorticoid-mediated beta cell death
    E. Reich, A. Tamary, Ronit Vogt Sionov, Danielle Melloul · 2012 · Diabetologia
  56. Chronic glucocorticoid treatment enhances lipogenic activity in visceral adipocytes of male Wistar rats
    Patrícia Chimin, Talita da Silva Mendes de Farias, Francisco Leonardo Torres‐Leal, Andressa Bolsoni Lopes, Amanda Baron Campaña, Sandra Andreotti, Fábio Bessa Lima · 2014 · Acta Physiologica
  57. Prolactin, progesterone, and dexamethasone coordinately and adversely regulate glucokinase and cAMP/PDE cascades in MIN6 β-cells
    Jianhua Shao, Liping Qiao, Jacob E. Friedman · 2004 · American Journal of Physiology-Endocrinology and Metabolism
  58. Glucocorticoid signalling affects pancreatic development through both direct and indirect effects
    Emilie Gesina, Bertrand Blondeau, Aude Milet, I. Le Nin, Bélinda Duchêne, Paul Czernichow, Raphaël Scharfmann, François Tronche, Bernadette Bréant · 2006 · Diabetologia
  59. The Role of Isotretinoin Therapy for Cushing’s Disease: Results of a Prospective Study
    Lúcio Vilar, José Luciano Albuquerque, Ruy Lyra, Erik Trovão Diniz, Frederico Rangel Filho, Patrícia Sampaio Gadelha, Ana Carolina Thé, George Robson Ibiapina, Barbara Sales Gomes, Vera Santos et al. · 2016 · International Journal of Endocrinology
  60. Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome
    Trementino, Laura, Appolloni, Gloria, Concettoni, Carolina, Cardinaletti, Marina, Boscaro, Marco, Arnaldi, Giorgio · 2012 · European Journal of Endocrinology
  61. The Smad6-Histone Deacetylase 3 Complex Silences the Transcriptional Activity of the Glucocorticoid Receptor
    Takamasa Ichijo, Antonis Voutetakis, Ana P. Cotrim, Nisan Bhattachryya, Makiko Fujii, George Panagiotis Chrousos, Tomoshige Kino · 2005 · Journal of Biological Chemistry
  62. FKBP51 regulation of AKT/protein kinase B phosphorylation
    Liewei Wang · 2011 · Current Opinion in Pharmacology
  63. The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship?: The size of AI correlates with insulin resistance
    Muscogiuri, Giovanna, Sorice, Gian Pio, Prioletta, Annamaria, Mezza, Teresa, Cipolla, Clelia, Salomone, Enrica, Giaccari, Andrea, Pontecorvi, Alfredo, Della Casa, Silvia · 2011 · Clinical Endocrinology
  64. A probabilistic model for Cushing’s syndrome screening in at-risk populations: a prospective multicenter study
    León-Justel, Antonio, Madrazo-Atutxa, Ainara, Alvarez-Rios, Ana I., Infantes-Fontán, Rocio, Garcia-Arnés, Juan A., Lillo-Muñoz, Juan A., Aulinas, Anna, Urgell-Rull, Eulàlia, Boronat, Mauro, Sánchez-de-Abajo, Ana et al. · 2016 · The Journal of Clinical Endocrinology &amp; Metabolism
  65. Dexamethasone suppresses phospholipase C activation and insulin secretion from isolated rat islets
    Walter S. Zawalich, Gregory J. Tesz, Hanae Yamazaki, Kathleen C. Zawalich, William M. Philbrick · 2005 · Metabolism
  66. HES1 is a master regulator of glucocorticoid receptor-dependent gene expression
    Revollo, Javier R., Oakley, Robert H., Lu, Nick Z., Kadmiel, Mahita, Gandhavadi, Maheer, Cidlowski, John A. · 2013 · Science Signaling
  67. Extended treatment of Cushing’s disease with pasireotide: results from a 2-year, Phase II study
    Marco Boscaro, Jerome Yves Bertherat, James W. Findling, Maria Fleseriu, A. B. Atkinson, Stephan Petersenn, Jochen Schopohl, Peter J. Snyder, G. Hughes, Andrew Trovato et al. · 2013 · Pituitary
  68. A retrospective study comparing neutral protamine hagedorn insulin with glargine as basal therapy in prednisone-associated diabetes mellitus in hospitalized patients
    Dhital, Subarna M., Shenker, Yoram, Meredith, Melissa, Davis, Dawn Belt · 2012 · Endocrine Practice
  69. Conditional Ablation of Mediator Subunit MED1 (MED1/PPARBP) Gene in Mouse Liver Attenuates Glucocorticoid Receptor Agonist Dexamethasone-Induced Hepatic Steatosis
    Yuzhi Jia, Navin Viswakarma, Tao Fu, Songtao Yu, Mahendra S. Rao, Jayme Borensztajn, Janardan K. Reddy · 2009 · Gene Expression
  70. Cushing’s syndrome in a clinic population with diabetes
    Newsome, S., Chen, K., Hoang, J., Wilson, J. D., Potter, J. M., Hickman, P. E. · 2008 · Internal Medicine Journal
  71. Ketoconazole therapy: an efficacious alternative to achieve eucortisolism in patients with Cushing's syndrome.
    Daniel Moncet, Daniel J. Morando, Fabián Pitoia, Silvia B. Katz, M. Rossi, Oscar Domingo Bruno · 2007 · PubMed
  72. microRNA‐379 couples glucocorticoid hormones to dysfunctional lipid homeostasis
    Roldan M. de Guia, Adam J. Rose, Anke Sommerfeld, Oksana Seibert, Daniela Strzoda, Annika Zota, Yvonne Feuchter, Anja Krones, Tjeerd Sijmonsma, Milen Kirilov et al. · 2014 · The EMBO Journal
  73. Adrenal Incidentaloma—A Modern Disease with Old Complications
    Alberto Angeli, Massimo Terzolo · 2002 · The Journal of Clinical Endocrinology & Metabolism
  74. Glucocorticoid Effects on Adiponectin Expression
    Siddharth Sukumaran, Debra C. DuBois, William J. Jusko, Richard R. Almon · 2012 · Vitamins and hormones
  75. Glucose, dexamethasone, and the unfolded protein response regulate TRB3 mRNA expression in 3T3-L1 adipocytes and L6 myotubes
    S. Yacoub‐Wasef, Katherine A. Robinson, Mary Neale Berkaw, Maria Gordon Buse · 2006 · American Journal of Physiology-Endocrinology and Metabolism
  76. BclI Glucocorticoid Receptor Polymorphism Is Associated With Greater Body Fatness: The Hoorn and CODAM Studies
    Charlotte C. M. van Laake‐Geelen, Marleen M. J. van Greevenbroek, Elisabeth F. C. van Rossum, Nicolaas C. Schaper, Giel Nijpels, Leen M. ‘t Hart, Caspar Schalkwijk, Isabel Ferreira, Carla Kallen, Hans P. Sauerwein et al. · 2013 · The Journal of Clinical Endocrinology & Metabolism
  77. Glucocorticoids, bone and energy metabolism
    Mark Stuart Cooper, Markus J. Seibel, Hong Zhou · 2015 · Bone
  78. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue
    Ying Wang, Chaoying Yan, Limei Liu, Wei Wang, Hanze Du, Winnie Fan, Kabirullah Lutfy, Meisheng Jiang, Theodore C. Friedman, Yanjun Liu · 2014 · American Journal of Physiology-Endocrinology and Metabolism
  79. Liver X Receptors Regulate the Transcriptional Activity of the Glucocorticoid Receptor: Implications for the Carbohydrate Metabolism
    Nancy Nader, Sinnie Sin Man Ng, Yonghong Wang, Brent S. Abel, George Panagiotis Chrousos, Tomoshige Kino · 2012 · PLoS ONE
  80. Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial
    Renate E. van Genugten, Daniël H. van Raalte, Marcel H.A. Muskiet, Martijn W. Heymans, Petra J. W. Pouwels, D. Margriet Ouwens, Andrea Mari, Michaëla Diamant · 2013 · European Journal of Endocrinology
  81. Exogenous Glucocorticoids and a High-Fat Diet Cause Severe Hyperglycemia and Hyperinsulinemia and Limit Islet Glucose Responsiveness in Young Male Sprague-Dawley Rats
    Jacqueline Leah Beaudry, Anna M. D'souza, Trevor Teich, Robert G. Tsushima, Michael Charles Riddell · 2013 · Endocrinology
  82. Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans
    Bernhard H. Ludvik, Martin Clodi, Alexandra Kautzky‐Willer, M. Capek, E Hartter, Giovanni Pacini, Rudolf Prager · 1993 · Diabetologia
  83. Subclinical hypercortisolism in hospitalized patients with type 2 diabetes mellitus
    TANIGUCHI, Takao, HAMASAKI, Akihiro, OKAMOTO, Motozumi · 2008 · Endocrine Journal
  84. Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing’s syndrome and acromegaly
    Baroni, M. G., Giorgino, F., Pezzino, V., Scaroni, C., Avogaro, A. · 2016 · Journal of Endocrinological Investigation
  85. Effects of cabergoline on blood glucose levels in type 2 diabetic patients
    Adele Bahar, Zahra Kashi, Ezzatossadat Daneshpour · 2016 · Medicine
  86. Medical Treatment of Cushing’s Disease: Somatostatin Analogues and Pasireotide
    Alberto M Pedroncelli · 2010 · Neuroendocrinology
  87. Lipid abnormalities in patients with adrenal incidentalomas: role of subclinical hypercortisolism and impaired glucose metabolism
    Benedetta Masserini, Valentina Morelli, Serena Palmieri, Cristina Eller-Vainicher, Volha V. Zhukouskaya, Elisa Cairoli, Emanuela Orsi, P. Beck‐Peccoz, A. Spada, Iacopo Chiodini · 2015 · Journal of Endocrinological Investigation
  88. Glucocorticoid-Induced Suppression of β-Cell Proliferation Is Mediated by Mig6
    E. Scott Colvin, Hong-Yun Ma, Yi‐Chun Chen, Angelina M. Hernandez, Patrick T. Fueger · 2013 · Endocrinology
  89. Protein metabolism in glucocorticoid excess: study in Cushing’s syndrome and the effect of treatment
    Burt, Morton G., Gibney, James, Ho, Ken K. Y. · 2007 · American Journal of Physiology-Endocrinology and Metabolism
  90. Activation of the Dopamine Receptor Type-2 (DRD2) Promoter by 9-Cis Retinoic Acid in a Cellular Model of Cushing's Disease Mediates the Inhibition of Cell Proliferation and ACTH Secretion Without a Complete Corticotroph-to-Melanotroph Transdifferentiation
    Gianluca Occhi, Daniela Regazzo, Nora Maria Elvira Albiger, Filippo Ceccato, S. Ferasin, Massimo Scanarini, Luca Denaro, Chiara Cosma, Mario Plebani, Maria Francesca Cassarino et al. · 2014 · Endocrinology
  91. Pasireotide monotherapy in Cushing’s disease: a single-centre experience with 5-year extension of phase III Trial
    MacKenzie Feder, Jessica, Bourdeau, Isabelle, Vallette, Sophie, Beauregard, Hugues, Ste-Marie, Louis-Georges, Lacroix, André · 2014 · Pituitary
  92. 11-Dehydrocorticosterone Causes Metabolic Syndrome, Which Is Prevented when 11β-HSD1 Is Knocked Out in Livers of Male Mice
    Erika Harno, Elizabeth C. Cottrell, Brian George Keevil, Joanne deSchoolmeester, Mohammad Bohlooly‐Y, Harriet Andersén, Andrew V. Turnbull, Brendan Leighton, Anne E. White · 2013 · Endocrinology
  93. Update in the medical therapy of Cushing's disease
    Lynnette K. Nieman · 2013 · Current Opinion in Endocrinology Diabetes and Obesity
  94. FOXO1-dependent up-regulation of MAP kinase phosphatase 3 (MKP-3) mediates glucocorticoid-induced hepatic lipid accumulation in mice
    Feng, Bin, He, Qin, Xu, Haiyan · 2014 · Molecular and Cellular Endocrinology
  95. Management of Diabetes Mellitus in Cushing’s Syndrome
    Alia Munir, John D C Newell-Price · 2010 · Neuroendocrinology
  96. Angiopoietin-Like Protein 4 is Differentially Regulated by Glucocorticoids and Insulin in vitro and in vivo in Healthy Humans
    Daniël H. van Raalte, Myrte Brands, Mireille J. M. Serlie, Karin Mudde, Rinke Stienstra, Hans P. Sauerwein, Sander Kersten, Michaëla Diamant · 2012 · Experimental and Clinical Endocrinology & Diabetes
  97. Increased diagnostic probability of subclinical Cushing’s syndrome in a population sample of overweight adult patients with type 2 diabetes mellitus
    Caetano, Maria Silvia S., Silva, Regina do Carmo, Kater, Claudio E. · 2007 · Arquivos Brasileiros de Endocrinologia &amp; Metabologia
  98. Pasireotide (SOM230), a Novel Multireceptor‐Targeted Somatostatin Analogue, Is Well Tolerated When Administered as a Continuous 7‐Day Subcutaneous Infusion in Healthy Male Volunteers
    S. Petersenn, N. Unger, K. Hu, Brigitte Weisshaar, Yilong Zhang, E. Bouillaud, K. H. Reséndiz, Yan-Feng Wang, K. Mann · 2012 · Journal of clinical pharmacology
  99. Reduction of insulinotropic properties of GLP-1 and GIP after glucocorticoid-induced insulin resistance
    Marie Eriksen, David Hebbelstrup Jensen, Siri Tribler, Jens Juul Holst, Sten Madsbad, Thure Krarup · 2015 · Diabetologia
  100. Carbohydrate Metabolism in Hyperadrenocorticism
    Armando Aguiar Pupo, BERNARDO LEO WAJCHENBERG, J Schnaider · 1966 · Diabetes
  101. Nondiabetic patients with either subclinical Cushing's or nonfunctional adrenal incidentalomas have lower insulin sensitivity than healthy controls: Clinical implications
    Miomira Ivović, Ljiljana Marina, Svetlana Vujović, Milina Tančić‐Gajić, Milos M. Stojanovic, Nevena V. Radonjić, Milan M. Gajić, Ivan Soldatović, Dragan Micić · 2013 · Metabolism
  102. Glucocorticoids suppress GLP-1 secretion: possible contribution to their diabetogenic effects
    Camilla Krizhanovskii, Liselotte Fransson, Petra Wolbert, Henrik Ortsäter · 2015 · Clinical Science
  103. Evaluation of the Effects of Exenatide Administration in Patients with Type 2 Diabetes with Worsened Glycemic Control Caused by Glucocorticoid Therapy
    Koji Matsuo, Takuo Nambu, Yuki Matsuda, Yugo Kanai, Shin Yonemitsu, Seiji Muro, Shogo Oki · 2013 · Internal Medicine
  104. Fat tissue metabolism and adrenal steroid secretion
    Lamounier-Zepter, Valéria, Ehrhart-Bornstein, Monika · 2006 · Current Hypertension Reports
  105. Clinical outcome of subclinical Cushing's syndrome after surgical and conservative treatment
    Itaru Akaza, Takanobu Yoshimoto, Fumiko Iwashima, Chisato Nakayama, Masaru Doi, Hajime Izumiyama, Yukio Hirata · 2011 · Hypertension Research
  106. Islet-cell dysfunction induced by glucocorticoid treatment: potential role for altered sympathovagal balance?
    Daniël H. van Raalte, Kelly A.A. Kwa, Renate E. van Genugten, Maarten E. Tushuizen, Jens Juul Holst, Carolyn Fiona Deacon, John M. Karemaker, Robert J. Heine, Andrea Mari, Michaëla Diamant · 2012 · Metabolism
  107. A common intron 2 polymorphism of the glucocorticoid receptor gene is associated with insulin resistance in men
    Akheel A. Syed, Christina G. Halpin, Julie A. E. Irving, Nigel C. Unwin, Martin J. White, Raj S. Bhopal, Christopher P.F. Redfern, Jolanta U. Weaver · 2008 · Clinical Endocrinology
  108. Aldosterone impairs insulin responsiveness in U‐937 human promonocytic cells via the downregulation of its own receptor
    J. Campion, B. Maestro, S. Molero, N. Dȧvila, M. Carranza, C. Calle · 2002 · Cell Biochemistry and Function
  109. Clinical Characteristics and Metabolic Features of Patients with Adrenal Incidentalomas with or without Subclinical Cushing's Syndrome
    Bo‐Yeon Kim, A Reum Chun, Kyu-Jin Kim, Chan‐Hee Jung, Sung Koo Kang, Ji‐Oh Mok, Chul‐Hee Kim · 2014 · Endocrinology and Metabolism
  110. Gene expression changes in subcutaneous adipose tissue due to Cushing's disease
    Irit Hochberg, Innocence C. Harvey, Quynh T. Tran, Erin J. Stephenson, Ariel L. Barkan, Alan R. Saltiel, William F. Chandler, Dave Bridges · 2015 · Journal of Molecular Endocrinology
  111. Differential expression of rat pancreatic islet Beta-cell glucose transporter (GLUT 2), proinsulin and islet amyloid polypeptide genes after prolonged fasting, insulin-induced hypoglycaemia and dexamethasone treatment
    Laszlo I Koranyi, R. E. Bourey, JOHN W. TURK, Mike M. Mueckler, M. Alan Permutt · 1992 · Diabetologia
  112. Do patients with type 2 diabetes mellitus have an increased prevalence of Cushing’s syndrome?
    Krarup, Therese, Krarup, Thure, Hagen, Claus · 2012 · Diabetes/Metabolism Research and Reviews
  113. Laparoscopic adrenalectomy in patients with subclinical Cushing syndrome
    Perysinakis, Iraklis, Marakaki, Chrisanthi, Avlonitis, Spyridon, Katseli, Anastasia, Vassilatou, Evangeline, Papanastasiou, Lambrini, Piaditis, George, Zografos, George N. · 2013 · Surgical Endoscopy
  114. Rational, Effective Metyrapone Treatment of ACTH-Independent Bilateral Macronodular Adrenocortical Hyperplasia (AIMAH).
    Nariko Omori, Kaoru Nomura, Kazue OMORI, Kazue Takano, Takao Obara · 2001 · Endocrine Journal
  115. Up-to 5-year efficacy of pasireotide in a patient with Cushing’s disease and pre-existing diabetes: literature review and clinical practice considerations
    Laura Trementino, Marina Cardinaletti, Carolina Concettoni, Giorgia Marcelli, Marco Boscaro, Giorgio Arnaldi · 2014 · Pituitary
  116. Screening for subclinical Cushing’s syndrome in type 2 diabetes mellitus: low false-positive rates with nocturnal salivary cortisol
    Gagliardi, L., Chapman, I. M., O’Loughlin, P., Torpy, D. J. · 2010 · Hormone and Metabolic Research
  117. Novel Transgenic Mice for Inducible Gene Overexpression in Pancreatic Cells Define Glucocorticoid Receptor-Mediated Regulations of Beta Cells
    Bertrand Blondeau, Iman Sahly, Emmanuelle Massouridès · 2012 · PLoS ONE
  118. Safety profile and metabolic effects of 14 days of treatment with DIO-902: results of a phase IIa multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in patients with type 2 diabetes mellitus
    SCHWARTZ, S, RENDELL, M, AHMANN, A, THOMAS, A, ARAUZPACHECO, C, WELLES, B · 2008 · Clinical Therapeutics
  119. Investigation of the mechanisms contributing to the compensatory increase in insulin secretion during dexamethasone-induced insulin resistance in rhesus macaques
    Bethany P. Cummings, Andrew A. Bremer, Timothy J. Kieffer, David A. D’Alessio, Peter Joseph Havel · 2012 · Journal of Endocrinology
  120. A Single-Center 10-Year Experience with Pasireotide in Cushing’s Disease: Patients’ Characteristics and Outcome
    Laura Trementino, Grazia Michetti, Alessia Angeletti, Giorgia Marcelli, Carolina Concettoni, C. Cardinaletti, Barbara Polenta, Marco Boscaro, Giorgio Arnaldi · 2016 · Hormone and Metabolic Research
  121. Mitogen-activated protein kinases and protein phosphatase 5 mediate glucocorticoid-induced cytotoxicity in pancreatic islets and β-cells
    Liselotte Fransson, Victoria Rosengren, Titu Kumar Saha, Nina Grankvist, Tohidul Islam, Richard E. Honkanen, Åke Sjöholm, Henrik Ortsäter · 2013 · Molecular and Cellular Endocrinology
  122. The Frequency of Type 2 Diabetic Patients who Meet the Endocrinological Screening Criteria of Subclinical Cushing's Disease
    Hiroshi Murakami, Takeshi Nigawara, Satoru Sakihara, Kazunori Kageyama, Maki Yamashita, Kota Matsuki, Jutaro Tanabe, Jun Matsui, Naoki Tamasawa, Toshihiro Suda · 2010 · Endocrine Journal
  123. Glucocorticoids regulate somatostatin peptide and steady state messenger ribonucleic acid levels in normal rat tissues and in a somatostatin-producing islet tumor cell line (1027B2).
    Dimitri N. Papachristou, Jun‐Li Liu, Yogesh Patel · 1994 · Endocrinology
  124. N-acetylcysteine protects pancreatic islet against glucocorticoid toxicity
    Letícia Prates Roma, Camila Aparecida Machado de Oliveira, Everardo M. Carneiro, Gabriela Girão de Albuquerque, Antonio Carlos Boschero, Kleber L.A. Souza · 2011 · Redox Report
  125. JNK and IKKβ phosphorylation is reduced by glucocorticoids in adipose tissue from insulin-resistant rats
    Katia Motta, Amanda Marreiro Barbosa, Franciane Bobinski, Antonio Carlos Boschero, Alex Rafacho · 2014 · The Journal of Steroid Biochemistry and Molecular Biology
  126. The hidden but positive role for glucocorticoids in the regulation of growth hormone-producing cells
    Hana Vakili, Peter A. Cattini · 2012 · Molecular and Cellular Endocrinology
  127. Bromocriptine-QR therapy for the management of type 2 diabetes mellitus: developmental basis and therapeutic profile summary
    Philip Raskin, Anthony H. Cincotta · 2015 · Expert Review of Endocrinology & Metabolism
  128. Response of the Blood Glucose to Glucocorticoids in Man: Determination of the Hyperglycemic Potencies of Glucocorticoids
    Kelly M West · 1959 · Diabetes
  129. Improvement in Insulin Sensitivity During Mifepristone Treatment of Cushing Syndrome:Early and Late Effects
    Amisha Wallia, Kathleen Colleran, Jonathan Q. Purnell, Coleman Gross, Mark E. Molitch · 2013 · Diabetes Care
  130. Reciprocal relationship between the level of circulating cortisol and growth hormone secretion in response to growth hormone-releasing hormone in man: studies in patients with adrenal insufficiency
    A Giustina, Enrico Bresciani, Simonetta Bossoni, Laura Chiesa, Valentina Misitano, William B. Wehrenberg, Johannes D. Veldhuis · 1994 · The Journal of Clinical Endocrinology & Metabolism
  131. Glucocorticoid Excess Increases Hepatic 11β-HSD-1 Activity in Humans: Implications in Steroid-Induced Diabetes
    Simmi Dube, Michael Q. Slama, Ananda Basu, Robert A. Rizza, Rita Basu · 2015 · The Journal of Clinical Endocrinology & Metabolism
  132. Increased lipolysis of subcutaneous abdominal adipose tissue and altered noradrenergic activity in patients with Cushing‘s syndrome: an in vivo microdialysis study
    Michal Kršek, M Rosická, Jara Nedvidkova, Václav Hána, J Marek, Martin Haluzı́k, Edwin W. Lai, Karel Pacák · 2006 · Physiological Research
  133. Myostatin inhibits proliferation and insulin-stimulated glucose uptake in mouse liver cells
    Rani Watts, Mostafa Ghozlan, Curtis C. Hughey, Virginia L. Johnsen, Jane Shearer, Dustin S. Hittel · 2014 · Biochemistry and Cell Biology
  134. Effects of Glucocorticoid Treatment on β- and α-Cell Mass in Japanese Adults With and Without Diabetes
    Seiji Sato, Yoshifumi Saisho, Jun Inaishi, Kinsei Kou, Rie Murakami, Taketo Yamada, Hiroshi Itoh · 2015 · Diabetes
  135. Expression of microRNA-26b, an obesity-related microRNA, is regulated by free fatty acids, glucose, dexamethasone and growth hormone in human adipocytes
    Guangfeng Xu, Chunmei Shi, Chenbo Ji, Guixian Song, Ling Chen, Lei Yang, Yaping Zhao, Xirong Guo · 2014 · Molecular Medicine Reports
  136. Predicting the probability of successful efficacy of a dissociated agonist of the glucocorticoid receptor from dose–response analysis
    Daniela J. Conrado, Sriram Krishnaswami, Satoshi Shoji, Sheela Kolluri, Judith Hey‐Hadavi, Dorothy McCabe, Ricardo Rojo, Brinda K. Tammara · 2016 · Journal of Pharmacokinetics and Pharmacodynamics
  137. Preserved GLP-1 Effects in a Diabetic Patient with Cushing's Disease
    Robert A. Ritzel, N. Kleine, Jens Juul Holst, B. Willms, Wolff Schmiegel, Michael Albrecht Nauck · 2007 · Experimental and Clinical Endocrinology & Diabetes
  138. Cardio‐metabolic consequences of glucocorticoid replacement: relevance of ultradian signalling
    David Henley, Stafford Louis Lightman · 2014 · Clinical Endocrinology
  139. INCB-13739, an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor for the treatment of type 2 diabetes.
    Atul Kumar Tiwari · 2010 · PubMed
  140. Long-term study of subclinical Cushing^|^rsquo;s syndrome shows high prevalence of extra-adrenal malignancy in patients with functioning bilateral adrenal tumors
    Hisaya Kawate, Michiko Kohno, Yayoi Matsuda, Yuko Akehi, Makito Tanabe, Toshihiro Horiuchi, Keizo Ohnaka, Masatoshi Nomura, Toshihiko Yanase, Ryoichi Takayanagi · 2014 · Endocrine Journal
  141. Ketoconazole enantiomer for the treatment of diabetes mellitus
    Arakaki, Richard, Welles, Bernice · 2010 · Expert Opinion on Investigational Drugs
  142. Cushing’s syndrome in type 2 diabetes patients with poor glycemic control
    Aşkın Güngüneş, Mustafa Şahi̇n, Taner Demirci, Bekir Uçan, Evrim Çakır, Müyesser Saykı Arslan, İlknur Öztürk Ünsal, Başak Karbek, Mustafa Çalışkan, Mustafa Özbek et al. · 2014 · Endocrine
  143. The Dehydrogenase Hypothesis
    Conor P. Woods, Jeremy Tomlinson · 2015 · Advances in experimental medicine and biology
  144. Low-dose octreotide is able to cause a maximal inhibition of the glycemic responses to a mixed meal in obese type 2 diabetic patients treated with insulin
    ANDREA GIUSTINA, Angela Girelli, Maria Grazia Buffoli, A. Cimino, Fabio Legati, Umberto Valentini, Gianni Giustina · 1991 · Diabetes Research and Clinical Practice
  145. Is it worthwhile to screen patients with type 2 diabetes mellitus for subclinical Cushing’s syndrome?
    Budyal, Sweta, Jadhav, Swati Sachin, Kasaliwal, Rajeev, Patt, Hiren, Khare, Shruti, Shivane, Vyankatesh, Lila, Anurag R, Bandgar, Tushar, Shah, Nalini S · 2015 · Endocrine Connections
  146. Impact of glucocorticoid receptor gene (NR3C1) polymorphisms in Turkish patients with metabolic syndrome
    Kaya, Z., Caglayan, S., Akkiprik, M., Aral, C., Ozisik, G., Ozata, M., Ozer, A. · 2016 · Journal of Endocrinological Investigation
  147. Pancreatic renin-angiotensin-aldosterone system in the cardiometabolic syndrome and type 2 diabetes mellitus
    Hayden, Melvin R., Sowers, James R. · 2008 · Journal of the CardioMetabolic Syndrome
  148. Cabergoline effect on blood sugar in type 2 diabetic patients with oral agent failure.
    S. Morteza Taghavi, Seyyede Sedighe Fatemi, Hale Rokni · 2012 · PubMed
  149. Glycated albumin is set lower in relation to plasma glucose levels in patients with Cushing's syndrome
    Tetsuhiro Kitamura, Michio Otsuki, Daisuke Tamada, Yukiko Tabuchi, Kosuke Mukai, Shinya Morita, Soji Kasayama, Iichiro Shimomura, Masafumi Koga · 2013 · Clinica Chimica Acta
  150. Effects of excess corticosterone on LKB1 and AMPK signaling in rat skeletal muscle
    G. Nathan Nakken, Daniel L. Jacobs, David M. Thomson, Natasha Fillmore, W. W. Winder · 2009 · Journal of Applied Physiology
  151. Mifepristone for ectopic ACTH secretion in metastatic endocrine carcinomas: report of two cases.
    Philippe Alexandre Cassier, Sawsan Abou-Amara-Olivieri, Pascal Artru, Marie-George Lapalus, Jean Paul Riou, Catherine Lombard‐Bohas · 2008 · European Journal of Endocrinology
  152. Transcriptional co-factors and hepatic energy metabolism
    Anke Sommerfeld, Anja Krones, Stephan Herzig · 2010 · Molecular and Cellular Endocrinology
  153. Glucocorticoid Excess Induces Accumulation of Cardiac Glycogen and Triglyceride: Suggested Role for AMPK
    Prasanth Puthanveetil, Brian B. Rodrigues · 2013 · Current Pharmaceutical Design
  154. Low positive predictive value of midnight salivary cortisol measurement to detect hypercortisolism in type 2 diabetes
    Charlotte Steffensen, Henrik Holm Thomsen, Olaf M. Dekkers, Jens Sandahl Christiansen, Jørgen Rungby, Jens Otto Lunde Jørgensen · 2016 · Clinical Endocrinology
  155. Thioredoxin Interacting Protein Is a Potential Regulator of Glucose and Energy Homeostasis in Endogenous Cushing's Syndrome
    Tove Lekva, Jens Bollerslev, Afaf Sahraoui, Hanne Scholz, Hege Bøyum, Johan Arild Evang, Kristin Godang, Pål Aukrust, Thor Ueland · 2013 · PLoS ONE
  156. Effets du glucose et de l'arginine sur la s�cr�tion d'insuline au cours des syndromes de Cushing
    Elisabeth Modigliani, Georges Strauch, JEAN PIERRE LUTON, Henri Bricaire · 1970 · Diabetologia
  157. Glucococorticoid-Induced Death of Pancreatic Beta Cells: An Organized Chaos
    Joselyn Rojas, Mervin Chávez-Castillo, Mervin Chávez-Castillo, Mayela Cabrera, Mayela Cabrera, Valmore Bermúdez, Valmore Bermúdez · 2015 · PubMed
  158. Assessment of long-term efficacy and safety of metyrapone monotherapy in a patient with ACTH-independent macronodular adrenal hyperplasia
    Masanori Yoshida, Hiroshi Umeda, Shintaro Iwama, Seiko Nakayama, Misaki Miyata, Koichiro Ogawa, Harumi Maeda, Yutaka Oiso · 2011 · Endocrine
  159. Modulatory effect of BclI GR gene polymorphisms on the obesity phenotype in Brazilian patients with Cushing's disease
    Ricardo P.P. Moreira, Tânia A.S.S. Bachega, Márcio Carlos Machado, Berenice Bilharinho Mendonca, Marcello D. Bronstein, Maria Candida Barisson Villares Fragoso · 2013 · Clinics
  160. Increased Protein and mRNA Expression of Resistin After Dexamethasone Administration
    Daimei Sasayama, Hiroaki Hori, Shôji Nakamura · 2014 · Hormone and Metabolic Research
  161. Cortisone induces insulin resistance in C2C12 myotubes through activation of 11beta‐hydroxysteroid dehydrogenase 1 and autocrinal regulation
    Seung Yeon Park, Ji Hyun Bae, Young Sik Cho · 2013 · Cell Biochemistry and Function
  162. Effectiveness of chronic treatment with ketoconazole in a patient with diabetic Cushing's disease resistant to surgery.
    Meral Mert, Gönenç Kocabay · 2011 · PubMed
  163. Cortisol Regulation in the Metabolic Syndrome. A Novel Therapeutic Approach
    Marin, Per, S. Birketvedt, Grethe · 2010 · Immunology‚ Endocrine &amp; Metabolic Agents in Medicinal Chemistry